AtriCure Expansion Plans to Bring 240,000 Square Feet and Hundreds of High-Paying Jobs to Mason Headquarters

AtriCure Announces $45M Headquarters Expansion in Mason

Expansion to Create Hundreds of High-Paying Jobs, Increase Headquarters to 240,000 Square Feet

AtriCure, Inc., a leading innovator in atrial fibrillation (AF) solutions, today announced a $45 million expansion of its Mason headquarters.

The expansion will add 100,000 square feet to the company's existing facility, bringing its total footprint to 240,000 square feet.

The expansion is expected to create hundreds of high-paying jobs in Mason, including positions in research and development, manufacturing, and administration

• The expansion is part of AtriCure's long-term growth strategy.
• The company has experienced significant growth in recent years, driven by the success of its left atrial appendage closure (LAAC) technology.
• LAAC is a minimally invasive procedure that is used to prevent stroke in patients with AF.

The expansion will allow AtriCure to increase its production capacity to meet the growing demand for its LAAC technology.

It will also provide the company with additional space for research and development, which will help it to continue to innovate and develop new technologies for the treatment of AF.

"This expansion is a major milestone for AtriCure," said David J. Daly, President and CEO of AtriCure.

"It is a testament to the hard work and dedication of our employees, and it will allow us to continue to grow and provide innovative solutions for the treatment of AF."

The expansion is expected to be completed in 2024.

AtriCure is a medical device company that develops, manufactures, and sells products for the treatment of AF.

The company's products are used in more than 100 countries around the world.

AtriCure is headquartered in Mason, Ohio, and has operations in the United States, Europe, and Asia.

For more information, visit www.atricure.com.